IDO1 and Hodgkins lymphoma: Higher IDO expression was found in EBV-positive cases, high Ann Arbor stages, high International Prognostic Score (IPS), and in patients having B-symptoms, while the mixed cellularity type of Hodgkin lymphoma showed the highest expression and the nodular sclerosis (NS) type predominantly showed low expression.